Canadian Stock Trader

Category: News

News

  • Fairfax Partners With Wittington Investments in Acquisition of Boots

    TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has entered into agreements to partner with Wittington Investments, Limited (“Wittington”), the holding company of the Weston family based in Canada, to acquire from The Boots Group the Boots retail operations in the UK and Ireland, the Boots Opticians business, the No7 Beauty Company, and Boots’ Thailand and franchised businesses (collectively, “Boots”) for a total purchase price of approximately US$8.9 billion (inclusive of assumed debt) (the “Transaction”).

    Originally published via Source Article.

  • Fairfax Partners With Wittington Investments in Acquisition of Boots

    TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has entered into agreements to partner with Wittington Investments, Limited (“Wittington”), the holding company of the Weston family based in Canada, to acquire from The Boots Group the Boots retail operations in the UK and Ireland, the Boots Opticians business, the No7 Beauty Company, and Boots’ Thailand and franchised businesses (collectively, “Boots”) for a total purchase price of approximately US$8.9 billion (inclusive of assumed debt) (the “Transaction”).

    Originally published via Source Article.

  • Fairfax Partners with Wittington Investments in Acquisition of The Boots Group

    TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has entered into agreements to partner with Wittington Investments, Limited (“Wittington”), the holding company of the Weston family based in Canada, to acquire The Boots Group (“Boots”), the leading pharmacy and health and beauty retailer in the United Kingdom and Ireland, for a total purchase price of approximately US$8.9 billion (inclusive of assumed debt) (the “Transaction”).

    Originally published via Source Article.

  • Fairfax Partners with Wittington Investments in Acquisition of The Boots Group

    TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has entered into agreements to partner with Wittington Investments, Limited (“Wittington”), the holding company of the Weston family based in Canada, to acquire The Boots Group (“Boots”), the leading pharmacy and health and beauty retailer in the United Kingdom and Ireland, for a total purchase price of approximately US$8.9 billion (inclusive of assumed debt) (the “Transaction”).

    Originally published via Source Article.

  • Fairfax Partners with Wittington Investments in Acquisition of The Boots Group

    TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has entered into agreements to partner with Wittington Investments, Limited (“Wittington”), the holding company of the Weston family based in Canada, to acquire The Boots Group (“Boots”), the leading pharmacy and health and beauty retailer in the United Kingdom and Ireland, for a total purchase price of approximately US$8.9 billion (inclusive of assumed debt) (the “Transaction”).

    Originally published via Source Article.

  • Fairfax Partners with Wittington Investments in Acquisition of The Boots Group

    TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has entered into agreements to partner with Wittington Investments, Limited (“Wittington”), the holding company of the Weston family based in Canada, to acquire The Boots Group (“Boots”), the leading pharmacy and health and beauty retailer in the United Kingdom and Ireland, for a total purchase price of approximately US$8.9 billion (inclusive of assumed debt) (the “Transaction”).

    Originally published via Source Article.

  • Optimi Health to Present at the ThinkEquity Conference

    VANCOUVER, British Columbia, Oct. 07, 2026 (GLOBE NEWSWIRE) — Optimi Health Corp. (Nasdaq: OPTH) (CSE: OPTI) (FSE: 8BN) (“Optimi” or “the Company”), a commercial-stage pharmaceutical manufacturer and clinical-stage developer of regulated psychedelic drug products, today announced that it will participate in the ThinkEquity Conference taking place on October 15, 2026, at the Mandarin Oriental Hotel in New York City. Management will present a corporate overview at 4:00 p.m. Eastern time and will be available for one-on-one meetings with investors registered for the event.

    Originally published via Source Article.

  • ClicData Launches AI Agent That Lets Midmarket Teams Build Dashboards by Chat

    ClicData launches an AI Dashboard Builder, letting midmarket teams create and edit full dashboards from plain-language requests in seconds.

    Originally published via Source Article.

  • Ex-China Tungsten Supply Runs 21,000 Tonnes Short as 2027 Ban Nears

    News Provided by Market Updates on behalf of Western Star Resources Inc. 

    News Provided by Market Updates on behalf of Western Star Resources Inc.

    Originally published via Source Article.

  • Optimi Health to Present at the ThinkEquity Conference

    VANCOUVER, British Columbia, Oct. 07, 2026 (GLOBE NEWSWIRE) — Optimi Health Corp. (Nasdaq: OPTH) (CSE: OPTI) (FSE: 8BN) (“Optimi” or “the Company”), a commercial-stage pharmaceutical manufacturer and clinical-stage developer of regulated psychedelic drug products, today announced that it will participate in the ThinkEquity Conference taking place on October 15, 2026, at the Mandarin Oriental Hotel in New York City. Management will present a corporate overview at 4:00 p.m. Eastern time and will be available for one-on-one meetings with investors registered for the event.

    Originally published via Source Article.